{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:08:29Z","timestamp":1789690109380,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>CD164 (endolyn), a sialomucin, has been reported to play a role in the proliferation, adhesion, and differentiation of hematopoietic stem cells. The potential association of CD164 with tumorigenicity remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The clinicopathological correlation of ovarian cancer with CD164 was assessed in a 97-patient tumor tissue microarray. Overexpression or silence CD164 was to analyze the effect of CD164 on the proliferation, colony formation and apoptosis via a mouse xenograft and western blotting analysis. The subcellular localization of CD164 was collected in the immunohistochemical and confocal analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our data demonstrated that higher expression levels of CD164 were identified in malignant ovarian cancer cell lines, such as SKOV3 and HeyA8. The clinicopathological correlation analysis showed that the upregulation of CD164 protein was significantly associated with tumor grade and metastasis. The overexpression of CD164 in human ovarian epithelial surface cells promoted cellular proliferation and colony formation and suppressed apoptosis. These tumorigenicity effects of CD164 were reconfirmed in a mouse xenograft model. We also found that the overexpression of CD164 proteins increased the amounts of CXCR4 and SDF-1\u03b1 and activated the SDF-1\u03b1\/CXCR4 axis, inducing colony and sphere formation. Finally, we identified the subcellular localization of CD164 in the nucleus and cytosol and found that nuclear CD164 might be involved in the regulation of the activity of the CXCR4 promoter.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings suggest that the increased expression of CD164 is involved in ovarian cancer progression via the SDF-1\u03b1\/CXCR4 axis, which promotes tumorigenicity. Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-12-115","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T15:01:19Z","timestamp":1380985279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1\u03b1\/CXCR4 axis"],"prefix":"10.1186","volume":"12","author":[{"given":"Ai-Fang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Lien","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Yi-Hsin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,5]]},"reference":[{"key":"1192_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nrc1611","volume":"5","author":"H Naora","year":"2005","unstructured":"Naora H, Montell DJ: Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer. 2005, 5: 355-366.","journal-title":"Nat Rev Cancer"},{"key":"1192_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E: Ovarian cancer development and metastasis. Am J Pathol. 2010, 177: 1053-1064.","journal-title":"Am J Pathol"},{"key":"1192_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0029-7844(03)00123-6","volume":"101","author":"S Tingulstad","year":"2003","unstructured":"Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B: Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol. 2003, 101: 885-891.","journal-title":"Obstet Gynecol"},{"key":"1192_CR4","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","volume":"9","author":"L Dubeau","year":"2008","unstructured":"Dubeau L: The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008, 9: 1191-1197.","journal-title":"Lancet Oncol"},{"key":"1192_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc2946","volume":"10","author":"DD Bowtell","year":"2010","unstructured":"Bowtell DD: The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer. 2010, 10: 803-808.","journal-title":"Nat Rev Cancer"},{"key":"1192_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","volume":"25","author":"LG Hudson","year":"2008","unstructured":"Hudson LG, Zeineldin R, Stack MS: Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis. 2008, 25: 643-655.","journal-title":"Clin Exp Metastasis"},{"key":"1192_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","volume":"5","author":"RF Ozols","year":"2004","unstructured":"Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, Xu X, Hamilton TC: Focus on epithelial ovarian cancer. Cancer Cell. 2004, 5: 19-24.","journal-title":"Cancer Cell"},{"key":"1192_CR8","first-page":"3917","volume":"118","author":"Z Lu","year":"2008","unstructured":"Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y, Mills GB: The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest. 2008, 118: 3917-3929.","journal-title":"J Clin Invest"},{"key":"1192_CR9","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-10-0483","volume":"16","author":"G Yang","year":"2010","unstructured":"Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, Xue F, Mercado-Uribe I, Huang J, Lin SH: CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res. 2010, 16: 3875-3886.","journal-title":"Clin Cancer Res"},{"key":"1192_CR10","doi-asserted-by":"publisher","first-page":"e60817","DOI":"10.1371\/journal.pone.0060817","volume":"8","author":"P Ataie-Kachoie","year":"2013","unstructured":"Ataie-Kachoie P, Morris DL, Pourgholami MH: Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies. PLoS One. 2013, 8: e60817-","journal-title":"PLoS One"},{"key":"1192_CR11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1182\/blood-2006-05-023028","volume":"109","author":"S Forde","year":"2007","unstructured":"Forde S, Tye BJ, Newey SE, Roubelakis M, Smythe J, McGuckin CP, Pettengell R, Watt SM: Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells. Blood. 2007, 109: 1825-1833.","journal-title":"Blood"},{"key":"1192_CR12","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4049\/jimmunol.165.2.840","volume":"165","author":"R Doyonnas","year":"2000","unstructured":"Doyonnas R, Yi-Hsin Chan J, Butler LH, Rappold I, Lee-Prudhoe JE, Zannettino AC, Simmons PJ, Buhring HJ, Levesque JP, Watt SM: CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol. 2000, 165: 840-851.","journal-title":"J Immunol"},{"key":"1192_CR13","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.1074\/jbc.M706730200","volume":"283","author":"GU Bae","year":"2008","unstructured":"Bae GU, Gaio U, Yang YJ, Lee HJ, Kang JS, Krauss RS: Regulation of myoblast motility and fusion by the CXCR4-associated sialomucin, CD164. J Biol Chem. 2008, 283: 8301-8309.","journal-title":"J Biol Chem"},{"key":"1192_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2407-6-195","volume":"6","author":"AM Havens","year":"2006","unstructured":"Havens AM, Jung Y, Sun YX, Wang J, Shah RB, Buhring HJ, Pienta KJ, Taichman RS: The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer. 2006, 6: 195-","journal-title":"BMC Cancer"},{"key":"1192_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/07357907.2012.666692","volume":"30","author":"J Tang","year":"2012","unstructured":"Tang J, Zhang L, She X, Zhou G, Yu F, Xiang J, Li G: Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo. Cancer Invest. 2012, 30: 380-389.","journal-title":"Cancer Invest"},{"key":"1192_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10585-011-9433-5","volume":"29","author":"N Sakai","year":"2012","unstructured":"Sakai N, Yoshidome H, Shida T, Kimura F, Shimizu H, Ohtsuka M, Takeuchi D, Sakakibara M, Miyazaki M: CXCR4\/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer. Clin Exp Metastasis. 2012, 29: 101-110.","journal-title":"Clin Exp Metastasis"},{"key":"1192_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill F: Cancer and the chemokine network. Nat Rev Cancer. 2004, 4: 540-550.","journal-title":"Nat Rev Cancer"},{"key":"1192_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ejca.2010.09.028","volume":"47","author":"D Uchida","year":"2011","unstructured":"Uchida D, Onoue T, Kuribayashi N, Tomizuka Y, Tamatani T, Nagai H, Miyamoto Y: Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases. Eur J Cancer. 2011, 47: 452-459.","journal-title":"Eur J Cancer"},{"key":"1192_CR19","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-10-3143","volume":"71","author":"E Righi","year":"2011","unstructured":"Righi E, Kashiwagi S, Yuan J, Santosuosso M, Leblanc P, Ingraham R, Forbes B, Edelblute B, Collette B, Xing D: CXCL12\/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res. 2011, 71: 5522-5534.","journal-title":"Cancer Res"},{"key":"1192_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/path.2908","volume":"224","author":"YF Ping","year":"2011","unstructured":"Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC, Jiang T, Lin MC, Chen JH, Wang B, Zhang R: The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K\/AKT signalling. J Pathol. 2011, 224: 344-354.","journal-title":"J Pathol"},{"key":"1192_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ, Cantley LC: Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 2006, 441: 424-430.","journal-title":"Nature"},{"key":"1192_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5732\/cjc.013.10057","volume":"32","author":"KH Khan","year":"2013","unstructured":"Khan KH, Yap TA, Yan L, Cunningham D: Targeting the PI3K-AKT-mTOR signaling network in cancer. Chin J Cancer. 2013, 32: 253-265.","journal-title":"Chin J Cancer"},{"key":"1192_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/1568009611313030002","volume":"13","author":"M Cheung","year":"2013","unstructured":"Cheung M, Testa JR: Diverse mechanisms of AKT pathway activation in human malignancy. Curr Cancer Drug Targets. 2013, 13: 234-244.","journal-title":"Curr Cancer Drug Targets"},{"key":"1192_CR24","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1096\/fasebj.13.13.1699","volume":"13","author":"AJ Vila-Coro","year":"1999","unstructured":"Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortiz MC, Martinez AC, Mellado M: The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK\/STAT pathway. FASEB J. 1999, 13: 1699-1710.","journal-title":"FASEB J"},{"key":"1192_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bbrc.2009.07.153","volume":"388","author":"M Monterrubio","year":"2009","unstructured":"Monterrubio M, Mellado M, Carrera AC, Rodriguez-Frade JM: PI3Kgamma activation by CXCL12 regulates tumor cell adhesion and invasion. Biochem Biophys Res Commun. 2009, 388: 199-204.","journal-title":"Biochem Biophys Res Commun"},{"key":"1192_CR26","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","volume":"44","author":"Z Yu","year":"2012","unstructured":"Yu Z, Pestell TG, Lisanti MP, Pestell RG: Cancer stem cells. Int J Biochem Cell Biol. 2012, 44: 2144-2151.","journal-title":"Int J Biochem Cell Biol"},{"key":"1192_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.2304","volume":"17","author":"H Clevers","year":"2011","unstructured":"Clevers H: The cancer stem cell: premises, promises and challenges. Nat Med. 2011, 17: 313-319.","journal-title":"Nat Med"},{"key":"1192_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nature11979","volume":"495","author":"A Flesken-Nikitin","year":"2013","unstructured":"Flesken-Nikitin A, Hwang CI, Cheng CY, Michurina TV, Enikolopov G, Nikitin AY: Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature. 2013, 495: 241-245.","journal-title":"Nature"},{"key":"1192_CR29","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-06-4429","volume":"67","author":"J Miki","year":"2007","unstructured":"Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 2007, 67: 3153-3161.","journal-title":"Cancer Res"},{"key":"1192_CR30","doi-asserted-by":"publisher","first-page":"e5125","DOI":"10.1371\/journal.pone.0005125","volume":"4","author":"K Beider","year":"2009","unstructured":"Beider K, Abraham M, Begin M, Wald H, Weiss ID, Wald O, Pikarsky E, Abramovitch R, Zeira E, Galun E: Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One. 2009, 4: e5125-","journal-title":"PLoS One"},{"key":"1192_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1634\/stemcells.21-2-162","volume":"21","author":"CP McGuckin","year":"2003","unstructured":"McGuckin CP, Forraz N, Baradez MO, Lojo-Rial C, Wertheim D, Whiting K, Watt SM, Pettengell R: Colocalization analysis of sialomucins CD34 and CD164. Stem Cells. 2003, 21: 162-170.","journal-title":"Stem Cells"},{"key":"1192_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/carcin\/bgp007","volume":"30","author":"R Sasaki","year":"2009","unstructured":"Sasaki R, Narisawa-Saito M, Yugawa T, Fujita M, Tashiro H, Katabuchi H, Kiyono T: Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes. Carcinogenesis. 2009, 30: 423-431.","journal-title":"Carcinogenesis"},{"key":"1192_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.oraloncology.2012.01.006","volume":"48","author":"KC Li","year":"2012","unstructured":"Li KC, Huang YH, Ho CY, Chu CY, Cha ST, Tsai HH, Ko JY, Chang CC, Tan CT: The role of IL-8 in the SDF-1alpha\/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma. Oral Oncol. 2012, 48: 507-515.","journal-title":"Oral Oncol"},{"key":"1192_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2012.01.001","volume":"316","author":"X Yu","year":"2012","unstructured":"Yu X, Chen D, Zhang Y, Wu X, Huang Z, Zhou H, Zhang Z: Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke. J Neurol Sci. 2012, 316: 141-149.","journal-title":"J Neurol Sci"},{"key":"1192_CR35","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1158\/1535-7163.MCT-12-1092","volume":"12","author":"X Sun","year":"2013","unstructured":"Sun X, Charbonneau C, Wei L, Yang W, Chen Q, Terek RM: CXCR4-Targeted Therapy Inhibits VEGF Expression and Chondrosarcoma Angiogenesis and Metastasis. Mol Cancer Ther. 2013, 12: 1163-1170.","journal-title":"Mol Cancer Ther"},{"key":"1192_CR36","doi-asserted-by":"publisher","first-page":"12132","DOI":"10.1074\/jbc.M111.302299","volume":"287","author":"G Chen","year":"2012","unstructured":"Chen G, Chen SM, Wang X, Ding XF, Ding J, Meng LH: Inhibition of chemokine (CXC motif) ligand 12\/chemokine (CXC motif) receptor 4 axis (CXCL12\/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. J Biol Chem. 2012, 287: 12132-12141.","journal-title":"J Biol Chem"},{"key":"1192_CR37","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1161\/ATVBAHA.111.229583","volume":"31","author":"Y Gong","year":"2011","unstructured":"Gong Y, Fan Y, Hoover-Plow J: Plasminogen regulates stromal cell-derived factor-1\/CXCR4-mediated hematopoietic stem cell mobilization by activation of matrix metalloproteinase-9. Arterioscler Thromb Vasc Biol. 2011, 31: 2035-2043.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1192_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","volume":"13","author":"R Du","year":"2008","unstructured":"Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G: HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008, 13: 206-220.","journal-title":"Cancer Cell"},{"key":"1192_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/cell.2013.0013","volume":"15","author":"D Yang","year":"2013","unstructured":"Yang D, Sun S, Wang Z, Zhu P, Yang Z, Zhang B: Stromal cell-derived factor-1 receptor CXCR4-overexpressing bone marrow mesenchymal stem cells accelerate wound healing by migrating into skin injury areas. Cell Reprogram. 2013, 15: 206-215.","journal-title":"Cell Reprogram"},{"key":"1192_CR40","doi-asserted-by":"publisher","first-page":"14759","DOI":"10.1073\/pnas.0702229104","volume":"104","author":"F Sierro","year":"2007","unstructured":"Sierro F, Biben C, Martinez-Munoz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, Batten M: Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12\/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A. 2007, 104: 14759-14764.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1192_CR41","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1182\/blood-2008-12-196618","volume":"113","author":"A Levoye","year":"2009","unstructured":"Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B: CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood. 2009, 113: 6085-6093.","journal-title":"Blood"},{"key":"1192_CR42","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1074\/jbc.M707465200","volume":"283","author":"J Wang","year":"2008","unstructured":"Wang J, Shiozawa Y, Wang Y, Jung Y, Pienta KJ, Mehra R, Loberg R, Taichman RS: The role of CXCR7\/RDC1 as a chemokine receptor for CXCL12\/SDF-1 in prostate cancer. J Biol Chem. 2008, 283: 4283-4294.","journal-title":"J Biol Chem"},{"key":"1192_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/1471-2407-13-347","volume":"13","author":"M Esencay","year":"2013","unstructured":"Esencay M, Sarfraz Y, Zagzag D: CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1alpha. BMC Cancer. 2013, 13: 347-","journal-title":"BMC Cancer"},{"key":"1192_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2199-12-44","volume":"12","author":"J Tang","year":"2011","unstructured":"Tang J, Luo Z, Zhou G, Song C, Yu F, Xiang J, Li G: Cis-regulatory functions of overlapping HIF-1alpha\/E-box\/AP-1-like sequences of CD164. BMC Mol Biol. 2011, 12: 44-","journal-title":"BMC Mol Biol"},{"key":"1192_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1677\/ERC-09-0085","volume":"17","author":"Y Arvidsson","year":"2010","unstructured":"Arvidsson Y, Bergstrom A, Arvidsson L, Kristiansson E, Ahlman H, Nilsson O: Hypoxia stimulates CXCR4 signalling in ileal carcinoids. Endocr Relat Cancer. 2010, 17: 303-316.","journal-title":"Endocr Relat Cancer"},{"key":"1192_CR46","first-page":"1501","volume":"23","author":"PF Wong","year":"2010","unstructured":"Wong PF, Abubakar S: Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells. Oncol Rep. 2010, 23: 1501-1516.","journal-title":"Oncol Rep"},{"key":"1192_CR47","doi-asserted-by":"publisher","first-page":"e51500","DOI":"10.1371\/journal.pone.0051500","volume":"8","author":"E Salomonnson","year":"2013","unstructured":"Salomonnson E, Stacer AC, Ehrlich A, Luker KE, Luker GD: Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy. PLoS One. 2013, 8: e51500-","journal-title":"PLoS One"},{"key":"1192_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1006\/gyno.2000.6084","volume":"81","author":"M Nitta","year":"2001","unstructured":"Nitta M, Katabuchi H, Ohtake H, Tashiro H, Yamaizumi M, Okamura H: Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. Gynecol Oncol. 2001, 81: 10-17.","journal-title":"Gynecol Oncol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-12-115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:56:23Z","timestamp":1630547783000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-12-115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,5]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1192"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-12-115","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,5]]},"assertion":[{"value":"7 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"115"}}